Isolation and Genome Sequencing of a Novel Pseudomonas aeruginosa Phage PA-YS35

Yun-He Jiang1, Jia-Qi Liu1, Chun-Yan Zhao1

  • 1Department of Pathogenobiology, College of Basic Medical Science, Jilin University, Changchun, 130021, Jilin, China.

Current Microbiology
|October 31, 2019
PubMed

Insights

A novel Pseudomonas aeruginosa phage, PA-YS35, was isolated and characterized. This lytic phage exhibits stability across a range of temperatures and pH levels, offering potential for therapeutic applications.

Area of Science:

  • Microbiology
  • Virology
  • Bacteriology

Background:

  • Pseudomonas aeruginosa is an opportunistic pathogen causing significant hospital-acquired infections.
  • Bacteriophages offer a promising alternative or adjunct to conventional antibiotics for treating bacterial infections.

Purpose of the Study:

  • To isolate and characterize a novel lytic bacteriophage targeting Pseudomonas aeruginosa.
  • To analyze the biological properties and genomic features of the isolated phage PA-YS35.

Main Methods:

  • Isolation of phage PA-YS35 from hospital sewage.
  • Biological property assessment (stability, growth curve).
  • Genomic analysis (DNA sequencing, RAST annotation, phylogenetic analysis).

Main Results:

  • Phage PA-YS35 is a Myoviridae family member, stable between -20 to 60°C and pH 4-9.
  • One-step growth curve revealed a 9-min latent period and a 21-min burst period, yielding ~380 progeny phages.
  • Genome is 93,296 bp linear double-stranded DNA with 49.35% GC content, containing 172 ORFs (41 with predicted functions).
  • Phylogenetic analysis indicated a close relationship with Pseudomonas phage PAK P1.

Conclusions:

  • Phage PA-YS35 is a robust lytic phage with potential for P. aeruginosa infection control.
  • Genomic data provides insights into phage-host interactions and phage biology.
  • Further research into PA-YS35 can advance phage therapy strategies.

Related Concept Videos